Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Combining Mycophenolate Mofetil With Methimazole on Remission of Newly Diagnosis Graves' Disease (3M-RGD Trial): an Open-label, Randomized Trial

NCT06068179 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Xiamen University as lead sponsor.

NCT NCT06068179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06068179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Combining Mycophenolate Mofetil With Methimazole on Remission of Newly Diagnosis Graves' Disease (3M-RGD Trial): an Open-label, Randomized Trial
Lead sponsor
The First Affiliated Hospital of Xiamen University
Phase
Phase 2/3
Overall status
Recruiting
Start date
October 16, 2023
Completion date
October 8, 2026
Enrollment
205 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

graves' disease